AHFS Drug Information Book

AHFS DI ina jeyaa e binndanɗe keewɗe jaɓaaɗe e sariya kisal renndo (kuulal 1861(t)(2)(B)(ii)(I)) ngam wonde ƴoogirde kuutoragol leɗɗe kaɓtorɗe kanseer ɗe ngalaa e nate.^[1] Nde yaltinaa ko e hitaande 1959 e innde Fedde Ameriknaare Farmasiyankooɓe Siistem Cellal.^[2]^[3]

Kadi ko kañum tan heddii e binndanɗe ɗe njaɓaa gila e fuɗɗoode.^[4]

Tuugnorgal

↑ ElizabethHalpern, Hogan Lovells-; Langbein, Stuart M.; Manning, Meredith; Roberts, Beth L.; Lakhani, Ali (14 August 2015). "And then there were five: CMS approves Wolters Kluwer Lexi-Drugs® as the fifth recognized authoritative compendium | Lexology" (in Engeleere). Retrieved 2018-03-30.
↑ "Medical Coverage Document". Centers for Medicare & Medicaid Services. cms.gov. Retrieved 6 January 2018.
↑ Abernethy, Amy (October 2012). "Role of Compendia in Determining what Drugs are Reimbursed". National Science Foundation.
↑ Butcher, Lola (2008-06-25). "Compendia Decisions Impact Off-Label Coverage". Oncology Times (in Engeleere). 30 (12): 29–30. doi:10.1097/01.COT.0000326167.89228.b6. ISSN 0276-2234.

[1] ElizabethHalpern, Hogan Lovells-; Langbein, Stuart M.; Manning, Meredith; Roberts, Beth L.; Lakhani, Ali (14 August 2015). "And then there were five: CMS approves Wolters Kluwer Lexi-Drugs® as the fifth recognized authoritative compendium | Lexology" (in Engeleere). Retrieved 2018-03-30.

[2] "Medical Coverage Document". Centers for Medicare & Medicaid Services. cms.gov. Retrieved 6 January 2018.

[3] Abernethy, Amy (October 2012). "Role of Compendia in Determining what Drugs are Reimbursed". National Science Foundation.

[4] Butcher, Lola (2008-06-25). "Compendia Decisions Impact Off-Label Coverage". Oncology Times (in Engeleere). 30 (12): 29–30. doi:10.1097/01.COT.0000326167.89228.b6. ISSN 0276-2234.

[1]

[2]

[3]

[4]